bc-ontologyGovernments, institutions, geography and law
Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological products

21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological products, “Actions for delays of generic drugs and biosimilar biological products”, is a U.S. Code section of Part A—Drugs and Devices; in force.

https://ontology.bommaritollc.com/id/01a0f06c-ccd8-745e-84b4-4a4530dbb4da
schema:Legislation
Download TurtleJSON-LDN-TriplesMarkdown
Cite this
21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological products. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-ccd8-745e-84b4-4a4530dbb4da

Elsewhere

Facts

adms:identifier
eli:cites
prov:wasDerivedFrom
schema:isPartOf
schema:legislationIdentifier
21 U.S.C. 355-2
schema:legislationJurisdiction
schema:legislationLegalForce
schema:legislationType
schema:name
Actions for delays of generic drugs and biosimilar biological productsen
schema:url
skos:prefLabel
21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological productsen

Related

Cited by (1)eli:cites

Its changes, from (1)eli:changes